Australia markets closed

BriaCell Therapeutics Corp. (BCT.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
1.5250+0.1150 (+8.16%)
At close: 03:58PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 25.78M
Enterprise value 24.50M
Trailing P/E 730.70
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)16.97
Enterprise value/revenue N/A
Enterprise value/EBITDA -198.85

Trading information

Stock price history

Beta (5Y monthly) 1.84
52-week change 3-82.90%
S&P500 52-week change 323.20%
52-week high 310.1982
52-week low 31.3000
50-day moving average 32.3092
200-day moving average 34.8799

Share statistics

Avg vol (3-month) 38.41k
Avg vol (10-day) 38.05k
Shares outstanding 518.28M
Implied shares outstanding 619.84M
Float 813.04M
% held by insiders 115.56%
% held by institutions 112.04%
Shares short (14 June 2024) 45.9k
Short ratio (14 June 2024) 40.44
Short % of float (14 June 2024) 40.04%
Short % of shares outstanding (14 June 2024) 40.03%
Shares short (prior month 15 May 2024) 41.1k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 302 Jan 2020
Ex-dividend date 4N/A
Last split factor 21009:1000
Last split date 305 Sept 2023

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 July 2023
Most-recent quarter (mrq)30 Apr 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-122.71%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -35.25M
Net income avi to common (ttm)-6M
Diluted EPS (ttm)-0.5100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)935.69k
Total cash per share (mrq)0.05
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)0.82
Book value per share (mrq)-0.37

Cash flow statement

Operating cash flow (ttm)-31.01M
Levered free cash flow (ttm)-17.95M